How Much Bacteriostatic Water for MOTS-C? (Chart)

Determining Diluent Volume for Lyophilized MOTS-c

Reconstituting MOTS-c typically requires adding 1.0 mL to 2.5 mL of sterile bacteriostatic water per lyophilized vial to achieve standard laboratory concentrations between 2.0 mg/mL and 10.0 mg/mL. The precise volume of diluent added depends directly on the starting mass of the lyophilized cake (commonly 5 mg or 10 mg) and the specific volumetric precision required for downstream in vitro assays or preclinical animal models. Selecting an appropriate volume ensures complete dissolution while keeping working concentrations within measurable pipette ranges.

When preparing MOTS-c peptide for laboratory evaluations, researchers must account for the solubility limits of short mitochondrial-derived peptides. Reconstitution with bacteriostatic water containing 0.9% benzyl alcohol prevents microbial growth during repeated laboratory sampling, making it the standard diluent for multi-use research vials maintained under refrigerated storage conditions.

Over-diluting the sample with excessive solvent can complicate micro-pipetting accuracy in low-volume microplate assays, whereas under-diluting may result in viscous solutions or incomplete peptide solubilization. Selecting standard diluent volumes such as 1.0 mL, 2.0 mL, 3.0 mL, or 5.0 mL simplifies mathematical conversions across our full catalog of research peptides.

Worked Concentration Chart for MOTS-c Reconstitution

To streamline assay preparation, the following reference table provides exact working concentrations based on vial mass and added diluent volume. All calculations assume complete dissolution of high-purity lyophilized MOTS-c cake in bacteriostatic water.

For 5 mg Lyophilized Vials: - Add 1.0 mL BAC Water -> Working Concentration: 5.0 mg/mL (5.0 µg/µL) - Add 2.0 mL BAC Water -> Working Concentration: 2.5 mg/mL (2.5 µg/µL) - Add 2.5 mL BAC Water -> Working Concentration: 2.0 mg/mL (2.0 µg/µL) - Add 5.0 mL BAC Water -> Working Concentration: 1.0 mg/mL (1.0 µg/µL)

For 10 mg Lyophilized Vials: - Add 1.0 mL BAC Water -> Working Concentration: 10.0 mg/mL (10.0 µg/µL) - Add 2.0 mL BAC Water -> Working Concentration: 5.0 mg/mL (5.0 µg/µL) - Add 3.0 mL BAC Water -> Working Concentration: 3.33 mg/mL (3.33 µg/µL) - Add 5.0 mL BAC Water -> Working Concentration: 2.0 mg/mL (2.0 µg/µL)

Selecting the proper volume depends on the sensitivity of the experimental setup. For instance, high-throughput microplate assays investigating cell viability or mitochondrial respiration often benefit from higher concentrations (5.0 mg/mL to 10.0 mg/mL) to minimize vehicle volume added to culture media.

Reconstitution Arithmetic and Volumetric Formulas

Calculating the final concentration of reconstituted MOTS-c relies on the fundamental formula $C = m / V$, where $C$ represents concentration in milligrams per milliliter (mg/mL), $m$ represents peptide mass in milligrams (mg), and $V$ represents diluent volume in milliliters (mL). To convert to microgram per microliter (µg/µL), note that 1.0 mg/mL is mathematically equivalent to 1.0 µg/µL.

For instance, if a researcher adds 2.0 mL of bacteriostatic water to a vial containing 10 mg of purified MOTS-c, the resulting concentration is calculated as $10 \text{ mg} / 2.0 \text{ mL} = 5.0 \text{ mg/mL}$. To deliver a target mass of 250 µg to a reaction mixture, the required micro-pipette volume ($V_a$) is derived using $V_a = \text{Target Mass} / C$. In this example, $250 \text{ µg} / (5.0 \text{ µg/µL}) = 50 \text{ µL}$.

When performing serial dilutions for cell culture assays, researchers can apply the standard dilution equation $C_1 V_1 = C_2 V_2$. Precise volumetric calculations prevent experimental drift and ensure consistent dosing across experimental replicates in preclinical studies.

Utilizing the Interactive Reconstitution Calculator

To minimize manual calculation errors during reagent preparation, laboratory personnel can utilize our automated reconstitution calculator. This tool allows researchers to input total peptide mass, desired volume, or target working concentration to instantly derive the required diluent additions.

Using digital tools streamlines workflow efficiency, particularly when managing multi-vial experimental blocks or scaling up wholesale research supplies for long-term study protocols. Automated verification helps maintain strict adherence to Good Laboratory Practices (GLP).

Researchers should verify all output values against manual arithmetic prior to reagent addition, ensuring that volumetric limits of both the peptide vial and analytical instruments are strictly observed.

Aliquoting, Storage, and Solution Stability Protocols

Lyophilized MOTS-c maintains robust chemical stability when stored at -20°C or -80°C in a desiccated environment. However, once reconstituted in bacteriostatic water, the peptide is subject to progressive peptide bond hydrolytic oxidation and potential aggregation over extended periods.

To maximize reconstituted stability, researchers should aliquot the stock solution into single-use micro-centrifuge tubes immediately following initial reconstitution. Aliquoting prevents degradation caused by repeated freeze-thaw cycles, which can fragment synthetic peptide chains and alter physical properties in downstream bioassays.

Aliquoted stock solutions should be stored at -20°C or -80°C for long-term research blocks, or kept refrigerated at 2°C to 8°C for short-term use within 14 to 21 days. Reconstituted solutions should never be stored in frost-free freezers due to temperature fluctuations during automatic defrost cycles.

Overview of MOTS-c: Mitochondrial Biology & Signaling Targets

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a naturally occurring mitochondrial-derived peptide composed of 16 amino acids. It represents a unique class of signaling molecules encoded within the mitochondrial genome rather than the nuclear genome.

Preclinical studies suggest that MOTS-c translocates to the nucleus under conditions of metabolic stress, where it interacts with adaptive transcription factors such as NRF2 and AP-1. In vitro data indicate that this nuclear translocation influences nuclear gene expression related to cellular homeostasis, lipid beta-oxidation, and glucose transport regulation.

Research in animal models continues to evaluate MOTS-c for its potential role in mitochondrial function, metabolic regulation, and exercise-capacity research. Investigating these pathways provides critical insight into cellular energy dynamics and age-related metabolic shifts.

Comparative Analysis: MOTS-c, SS-31, and Humanin

MOTS-c belongs to a broader class of peptides evaluated for mitochondrial targeting and cellular bioenergetics. Comparative preclinical evaluations frequently examine MOTS-c alongside other prominent mitochondrial research compounds, such as SS-31 and Humanin.

While MOTS-c acts primarily as a metabolic regulator that translocates to the nucleus during cellular stress, SS-31 operates directly at the inner mitochondrial membrane by binding cardiolipin to optimize electron transport chain efficiency. Conversely, Humanin—another mitochondrial-derived peptide—is extensively studied for cytoprotective mechanisms and anti-apoptotic signaling pathways.

Evaluating these distinct mechanisms within parallel preclinical models enables investigators to map mitochondrial signaling networks comprehensively. Selecting the appropriate compound depends on whether the study targets transcriptional metabolic control (MOTS-c), membrane cardiolipin dynamics (SS-31), or survival signaling pathways (Humanin).

Quality Metrics, Analytical Testing, and COA Verification

Reproducibility in preclinical research requires high-purity peptides free from synthesis side-products, TFA salts, and bacterial contamination. PX1 Research subjects every production lot of MOTS-c to rigorous analytical characterization in an ISO 17025 accredited laboratory.

Purity is verified through High-Performance Liquid Chromatography (HPLC), ensuring a purity threshold of ≥98%. Mass Spectrometry (MS) confirms exact molecular weight and structural identity, while Kinetic Chromogenic LAL assays verify strict endotoxin limits (<0.05 EU/mg) to prevent non-specific immune activation in cell culture models.

Researchers can review batch-specific data by accessing a verified lot-specific Certificate of Analysis for every order. All products are manufactured in USA-based, GMP-compliant facilities to support high-rigor bench research.

Reconstitution Best Practices in Preclinical Lab Environments

To execute seamless reconstitution of MOTS-c, lab technicians should observe standard aseptic techniques inside a laminar flow hood. Allow both the peptide vial and the bacteriostatic water to equilibrate to room temperature prior to diluent introduction.

Sanitize the rubber septum of the vial with 70% isopropyl alcohol. Using a sterile syringe, draw the exact calculated volume of bacteriostatic water and inject it slowly along the inner glass wall of the vial. Directing the stream against the wall prevents foaming and mechanical shear stress on the peptide structure.

Swirl the vial gently with a smooth circular motion until the lyophilized powder is completely dissolved. Never vortex reconstituted peptide solutions aggressively, as agitation can induce denaturation or aggregation. Verify visual clarity prior to aliquoting or downstream application.